Rheumatic fever

Rheumatic fever
Rheumatic Mitral Valvulitis: Gross; an excellent example of acute rheumatic fever lesion along line of closure of mitral valve Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10	I00-I02
ICD-9	390–392
DiseasesDB	11487
MedlinePlus	003940
eMedicine	med/3435  med/2922 emerg/509 ped/2006
MeSH	D012213

WikiDoc Resources for Rheumatic fever
Articles
Most recent articles on Rheumatic fever Most cited articles on Rheumatic fever Review articles on Rheumatic fever Articles on Rheumatic fever in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Rheumatic fever Images of Rheumatic fever Photos of Rheumatic fever Podcasts & MP3s on Rheumatic fever Videos on Rheumatic fever
Evidence Based Medicine
Cochrane Collaboration on Rheumatic fever Bandolier on Rheumatic fever TRIP on Rheumatic fever
Clinical Trials
Ongoing Trials on Rheumatic fever at Clinical Trials.gov Trial results on Rheumatic fever Clinical Trials on Rheumatic fever at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Rheumatic fever NICE Guidance on Rheumatic fever NHS PRODIGY Guidance FDA on Rheumatic fever CDC on Rheumatic fever
Books
Books on Rheumatic fever
News
Rheumatic fever in the news Be alerted to news on Rheumatic fever News trends on Rheumatic fever
Commentary
Blogs on Rheumatic fever
Definitions
Definitions of Rheumatic fever
Patient Resources / Community
Patient resources on Rheumatic fever Discussion groups on Rheumatic fever Patient Handouts on Rheumatic fever Directions to Hospitals Treating Rheumatic fever Risk calculators and risk factors for Rheumatic fever
Healthcare Provider Resources
Symptoms of Rheumatic fever Causes & Risk Factors for Rheumatic fever Diagnostic studies for Rheumatic fever Treatment of Rheumatic fever
Continuing Medical Education (CME)
CME Programs on Rheumatic fever
International
Rheumatic fever en Espanol Rheumatic fever en Francais
Business
Rheumatic fever in the Marketplace Patents on Rheumatic fever
Experimental / Informatics
List of terms related to Rheumatic fever

Cardiology Network
Discuss Rheumatic fever further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-in-Chief: Lance Christiansen, D.O.

Associate Editor: Cafer Zorkun, M.D., Ph.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Rheumatic fever The pathological, high-level, systemic, autoimmunological, inflammatory reaction, which is a sequela to an infection from a virulent strain of Streptococcus pyogenes bacteria, in an individual who has had prior, proper sensitization to Streptococcus pyogenes' autoantigens from prior infections by Streptococcus pyogenes, is termed rheumatic fever. The systemic signs and symptoms of rheumatic fever are caused by an attack on an individual's tissues by autoantibodies that are self-developed during an immunological response to Streptococcus pyogenes autoantigens. The diseases state of rheumatic fever is due to an individual's autoimmunological response to the autoantigens of Streptococcus pyogenes during an infection and not from the Streptococcus pyogenes infection itself.

General information

Rheumatic fever is common worldwide and responsible for many cases of damaged heart valves. In the Western countries, it became fairly rare since the 1960s, probably due to widespread use of antibiotics to treat streptococcus infections. While it is far less common in the United States since the beginning of the 20th century, there have been a few outbreaks since the 1980s. Although the disease seldom occurs, it is serious and has a mortality of 2–5%.

Rheumatic fever primarily affects children between ages 6 and 15 years and occurs approximately 20 days after strep throat or scarlet fever. In up to a third of cases, the underlying strep infection may not have caused any symptoms.

The rate of development of rheumatic fever in individuals with untreated strep infection is estimated to be 3%. The rate of development is far lower in individuals who have received antibiotic treatment. Persons who have suffered a case of rheumatic fever have a tendency to develop flare-ups with repeated strep infections.

The recurrence of rheumatic fever is relatively common in the absence of maintenance of low dose antibiotics, especially during the first three to five years after the first episode. Heart complications may be long-term and severe, particularly if valves are involved.

Diagnosis: modified Jones criteria

T. Duckett Jones, MD, first published these criteria in 1944. They have been periodically revised by the American Heart Association in collaboration with other groups. Two major criteria, or one major and two minor criteria, when there is also evidence of a previous strep infection, support the diagnosis of rheumatic fever.

Major criteria

• Carditis: inflammation of the heart muscle which can manifest as congestive heart failure with shortness of breath, pericarditis with a rub, or a new heart murmur.
• Migratory polyarthritis: a temporary migrating inflammation of the large joints, usually starting in the legs and migrating upwards.
• Sydenham's chorea (St. Vitus' dance): a characteristic series of rapid movements without purpose of the face and arms. This can occur very late in the disease.
• Erythema marginatum: a long lasting rash that begins on the trunk or arms as macules and spread outward to form a snakelike ring while clearing in the middle. This rash never starts on the face and is made worse with heat.
• Subcutaneous nodules (a form of Aschoff bodies): painless, firm collections of collagen fibers on the back of the wrist, the outside elbow, and the front of the knees. These now occur infrequently.

Minor criteria

• Fever: temperature elevation
• Arthralgia: Joint pain without swelling
• Laboratory abnormalities: increased Erythrocyte sedimentation rate, increased C reactive protein, leukocytosis
• Electrocardiogram abnormalities: a prolonged PR interval
• Evidence of Group A Strep infection: positive culture for Group A Strep, elevated or rising Antistreptolysin O titre
• Previous rheumatic fever or inactive heart disease

Other signs and symptoms

• Abdominal pain
• Nosebleeds

Pathophysiology

Rheumatic fever is a systemic disease affecting the peri-arteriolar connective tissue and can occur after an untreated Group A streptococcal pharyngeal infection. It is believed to be caused by antibody cross-reactivity. This cross-reactivity is a Type II hypersensitivity reaction and is termed molecular mimicry.

Usually, self reactive B cells remain anergic in the periphery without T cell co-stimulation. During a Strep. infection activated antigen presenting cells such as macrophages present the bacterial antigen to helper T cells. Helper T cells subsequently activate B cells and induce the production of antibodies against the cell wall of Streptococcus. However the antibodies may also react against the myocardium and joints, producing the symptoms of Rheumatic fever.

Group A streptococcus pyogenes has a cell wall composed of branched polymers which sometimes contain "M proteins" that are highly antigenic. The antibodies which the immune system generates against the "M proteins" may cross react with cardiac myofiber sarcolemma and smooth muscle cells of arteries, inducing cytokine release and tissue destruction. This inflammation occurs through direct attachment of complement and Fc receptor-mediated recruitment of neutrophils and macrophages. Characteristic Aschoff bodies, composed of swollen eosinophilic collagen surrounded by lymphocytes and macrophages can be seen on light microscopy. The larger macrophages may become Aschoff giant cells. Acute rheumatic valvular lesions may also involve a cell-mediated immunity reaction as these lesions predominantly contain T-helper cells and macrophages.

In acute RF, these lesions can be found in any layer of the heart and is hence called pancarditis. The inflammation may cause a serofibrinous pericardial exudates described as “bread-and-butter” pericarditis, which usually resolves without sequelae. Involvement of the endocardium typically results in fibrinoid necrosis and verrucae formation along the lines of closure of the left-sided heart valves. Warty projections arise from the deposition, while subendothelial lesions may induce irregular thickenings called MacCallum plaques.

Chronic rheumatic heart disease is characterized by repeated inflammation with fibrinous resolution. The cardinal anatomic changes of the valve include leaflet thickening, commissural fusion and shortening and thickening of the tendinous cords. RHD cause 99% of mitral stenosis often resulting in a “fish mouth” gross appearance.

Treatment

The management of acute rheumatic fever is geared toward the reduction of inflammation with anti-inflammatory medications such as aspirin or corticosteroids. Individuals with positive cultures for strep throat should also be treated with antibiotics. Another important cornerstone in treating rheumatic fever includes the continuous use of low dose antibiotics (such as penicillin, sulfadiazine, or erythromycin) to prevent recurrence.

Infection

Patients with positive cultures for streptococcus pyogenes should be treated with penicillin as long as allergy is not present. This treatment will not alter the course of the acute disease.

Inflammation

Patients with significant symptoms may require corticosteroids. Salicylates are useful for pain.

Heart failure

Some patients develop significant carditis which manifests as congestive heart failure. This requires the usual treatment for heart failure: diuretics and digoxin. Unlike normal heart failure, rheumatic heart failure responds well to corticosteroids.

Prevention

Prevention of recurrence is achieved by eradicating the acute infection and prophylaxis with antibiotics. The American Heart Association recommends daily or monthly prophylaxis continue long-term, perhaps for life.

Primary care physicians, nurses also have a role in prevention, primarily in screening school-aged children for sore throats that may be caused by Group A streptococci(especially Group A β Hemolytic Streptococcus pyogenes).

Pathological Findings

Images courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

• 

  Aortic Stenosis (Tricuspid aorta): Gross, good example of aortic stenosis due to rheumatic fever

• 

  Gross, an excellent example of mitral scarring due to rheumatic fever (healing phase of an infectious lesion).

• 

  Rheumatic mitral valvulitis: Gross, an excellent example of fibrosis, chorda thickening and shortening has thrombus around the large left atrium

• 

  Mitral valve: acute rheumatic fever

• 

  Aschoff bodies in rheumatic heart disease

External links

• Rheumatic fever information from Seattle Children's Hospital Heart Center

Template:WikiDoc Sources